These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22581533)

  • 1. Geographical distribution of a seropositive myasthenia gravis population.
    Heldal AT; Eide GE; Gilhus NE; Romi F
    Muscle Nerve; 2012 Jun; 45(6):815-9. PubMed ID: 22581533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
    Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
    Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
    Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
    Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
    Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
    S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
    Andersen JB; Heldal AT; Engeland A; Gilhus NE
    Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.
    Andersen JB; Engeland A; Owe JF; Gilhus NE
    Eur J Neurol; 2010 Dec; 17(12):1445-50. PubMed ID: 20491896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
    Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
    Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Heldal AT; Owe JF; Gilhus NE; Romi F
    Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
    [No Abstract]   [Full Text] [Related]  

  • 14. A population based epidemiological study on myasthenia gravis in Estonia.
    Oöpik M; Kaasik AE; Jakobsen J
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some epidemiological aspects of myasthenia gravis in Cuba].
    Cisneros AD; Luis RS; León R; Carrera PL
    Rev Neurol; 1996 Apr; 24(128):435-9. PubMed ID: 8721922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
    McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
    Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood onset myasthenia gravis.
    Raksadawan N; Kankirawatana P; Balankura K; Prateepratana P; Sangruchi T; Atchaneeyasakul LO
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S769-77. PubMed ID: 12403259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries.
    Boldingh MI; Maniaol AH; Brunborg C; Dekker L; Heldal AT; Lipka AF; Popperud TH; Niks EH; Verschuuren JJ; Tallaksen CM
    Neuroepidemiology; 2015; 44(4):221-31. PubMed ID: 26068011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.